secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-08-17T23:59:59+00:00
Accession:  0000947871-23-000871
Event type: other_material
Sentiment:  negative
Materiality: 0.35
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Shield of California to drop CVS Caremark as PBM except specialty; CVS reaffirms 2023 guidance
--------------------------------------------------------------------------------

- Blue Shield of California will use multiple pharmacy providers starting 2024; CVS Caremark retained only for specialty pharmacy.
- Partial contract termination has no impact on CVS's 2023 guidance and immaterial longer-term impact.
- CVS reaffirms 2023 GAAP diluted EPS range $6.53-$6.75, adjusted EPS $8.50-$8.70, cash flow from ops $12.5B-$13.5B.
- CVS states CVS Caremark remains the leading U.S. PBM by members and health plans served.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000094787123000871/0000947871-23-000871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000094787123000871/ss2400841_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-23-000871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer